Charles River Laboratories International Inc
NYSE:CRL
Charles River Laboratories International Inc
NYSE:CRL
Price:
214.51 USD
-1.24%
Market Closed
Updated:
May 29, 2024
Charles River Laboratories International Inc
Deferred Income Tax
|
Charles River Laboratories International Inc
Deferred Income Tax Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Deferred Income Tax Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Deferred Income Tax | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Charles River Laboratories International Inc
NYSE:CRL
|
Deferred Income Tax
$180.1m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
28%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Deferred Income Tax
$1.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-8%
|
|
|
Danaher Corp
NYSE:DHR
|
Deferred Income Tax
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Deferred Income Tax
$100.1m
|
CAGR 3-Years
42%
|
CAGR 5-Years
20%
|
CAGR 10-Years
5%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Deferred Income Tax
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Deferred Income Tax
$164m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
16%
|
See Also
What is Charles River Laboratories International Inc's Deferred Income Tax?
Deferred Income Tax
180.1m
USD
180.1m
USD
Based on the financial report for Mar 30, 2024, Charles River Laboratories International Inc's Deferred Income Tax amounts to 180.1m USD.
What is Charles River Laboratories International Inc's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 10Y
28%
28%
Over the last year, the Deferred Income Tax growth was -15%. The average annual Deferred Income Tax growth rates for Charles River Laboratories International Inc have been -5% over the past three years , 3% over the past five years , and 28% over the past ten years .
You don't have any saved screeners yet
